Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · IEX Real-Time Price · USD
0.765
+0.031 (4.20%)
Apr 23, 2024, 2:42 PM EDT - Market open
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $122.07 million as of April 23, 2024. Its market cap has decreased by -45.79% in one year.
Market Cap
122.07M
Enterprise Value
105.25M
1-Year Change
-45.79%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has increased from $30.70M to $122.07M, an increase of 297.63%. That is a compound annual growth rate of 22.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 120.00M | -6.32% |
Apr 18, 2024 | 128.10M | -1.31% |
Apr 17, 2024 | 129.80M | 8.80% |
Apr 16, 2024 | 119.30M | -1.97% |
Apr 15, 2024 | 121.70M | -2.95% |
Apr 12, 2024 | 125.40M | -5.36% |
Apr 11, 2024 | 132.50M | -2.00% |
Apr 10, 2024 | 135.20M | -4.52% |
Apr 9, 2024 | 141.60M | -7.39% |
Apr 8, 2024 | 152.90M | -3.78% |
Apr 5, 2024 | 158.90M | 5.37% |
Apr 4, 2024 | 150.80M | -1.76% |
Apr 3, 2024 | 153.50M | -1.22% |
Apr 2, 2024 | 155.40M | -5.19% |
Apr 1, 2024 | 163.90M | 14.86% |
Mar 28, 2024 | 142.70M | 8.85% |
Mar 27, 2024 | 131.10M | 2.90% |
Mar 26, 2024 | 127.40M | -0.16% |
Mar 25, 2024 | 127.60M | 1.75% |
Mar 22, 2024 | 125.40M | 5.11% |
Mar 21, 2024 | 119.30M | -3.40% |
Mar 20, 2024 | 123.50M | 4.48% |
Mar 19, 2024 | 118.20M | 3.23% |
Mar 18, 2024 | 114.50M | -2.22% |
Mar 15, 2024 | 117.10M | 6.84% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vor Biopharma | 124.15M |
Agenus | 120.86M |
Adagene | 120.44M |
TruBridge | 119.54M |
Outset Medical | 118.18M |
Relmada Therapeutics | 116.77M |
Coya Therapeutics | 116.20M |
OptiNose | 116.03M |